Regulus Therapeutics Inc (NASDAQ:RGLS)

18.52
Delayed Data
As of Feb 27
 -0.78 / -4.04%
Today’s Change
5.40
Today|||52-Week Range
25.60
+15.46%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Astrazeneca Plc
Sale11/12/20142,000,000$17.00$34.0M-5.61%
Xanthopoulos Kleanthis G
President & Chief Executive Officer
Sale1/28/201572,011$17.97$1.3M+4.87%
Gibson Neil W
Chief Scientific Officer
Sale1/28/201571,345$17.98$1.3M+4.87%
Alnylam Pharmaceuticals Inc
Sale10/22/201457,753$13.91$803.3K+34.69%
Isis Pharmaceuticals Inc
Sale10/22/201457,753$13.91$803.3K+34.69%
Xanthopoulos Kleanthis G
President & Chief Executive Officer
Sale1/29/201533,773$17.77$600.1K-0.32%
Xanthopoulos Kleanthis G
President & Chief Executive Officer
Sale1/29/201526,227$18.40$482.6K-0.32%
Xanthopoulos Kleanthis G
President & Chief Executive Officer
Sale1/28/201512,989$18.69$242.8K+4.87%
Alnylam Pharmaceuticals Inc
Sale10/22/201415,156$14.67$222.3K+34.69%
Isis Pharmaceuticals Inc
Sale10/22/201415,156$14.67$222.3K+34.69%
Page of 20

To view my watchlist

Not a member yet?

Sign up now for a free account